Skip to main content

Table 2 Univariate analyses & multiple logistic regression comparing baseline characteristics between responders and non-responders

From: Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluation

Univariate Analyses

Multiple logistic regression

Variable

Responders (n = 68)

Non-responders (n = 30)

Difference (95% CI)

p-value

Odds ratio

(95% CI)

p-value

Age (mean ± SEM)

44.8 ± 1.56

44.1 ± 2.16

-0.62

(-6.07 – 4.84)

p = 0.8230*

1.00

(0.96 to 1.04)

p = 0.8742

Gender (n [%] female)

57 [83.8%]

26 [86.7%]

OR 0.79 (0.26 – 2.66)

p > 0.9999†

1.07

(0.29 to 4.55)

p = 0.9240

Baseline headache days (median [IQR])

27 [22–28]

28 [28–28]

1

(0 – 2)

p = 0.0006

1.03

(0.77 to 1.36)

p = 0.8058

Number of previously tried treatments (median [IQR])

7 [6.25–8]

7 [6-8]

0

(-1 – 0)

p = 0.3922‡

1.29

(0.90 to 1.87)

p = 0.1701

Any medication overuse at baseline (n [%])**

35/63 [55.6%]

13/28

[46.4%]

OR 1.44 (0.56 – 3.40)

p = 0.50†

1.41

(0.52 – 3.89)

p = 0.5048

Daily headache at baseline (n [%])

33 [48.5%]

26 [86.7%]

OR 0.15 (0.05 – 0.44)

p = 0.0003

0.11

(0.01 – 0.73)

p = 0.0395

  1. * means compared with unpaired t-test
  2. medians compared with Mann–Whitney U-test
  3. contingency assessed with Fisher’s exact test
  4. OR Odds Ratio, CI Confidence interval, IQR Interquartile range